Kirsten rat sarcoma viral oncogene homologue (KRAS) mutation is one of the most prevalent genetic mutations in NSCLC, and its activation has been described in approximately 35% cases of NSCLC.5 Here, KRAS is linked to non-small cell lung carcinoma.